CEO Interview - 1HY26
Filed with ASX · · 4 pages · English
Summary by 6ix AI
This filing is an interview with Dr. Sam Hupert, CEO of Pro Medicus, discussing the company's half-year results and strategic updates. The CEO highlighted significant growth in underlying profit and a strong sales performance, with multiple new deals contributing to a substantial contracted volume. Additionally, the interview addresses the impact of AI on the industry and the company's ongoing investment strategies. Pro Medicus also reported on its successful implementations and the importance of its recent contracts in expanding its European presence.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
On 6ix: 6ix.com/news/ceo-interview-1hy26
In the deck
Story so far
Earlier from Pro Medicus
- Company Announcement - Interim Results
- Appendix 4D
- PME Response to speculation
- PME signs A$25M-7-Year Visage Open Archive Deal with BayCare
- Pro Medicus - AGM 2025 - Presentation
Later from Pro Medicus
- HY26 Results Presentation
- PME signs two 5-year contract renewals total minimum A$40M
- Visage Elevates AI Optimized Enterprise Imaging at HIMSS26
- Notification of buy-back - PME
- PME signs 5-year, A$23M contract with University of Maryland
Follow Pro Medicus into a list and get an email when it puts out news.
Follow Pro Medicus